Annual Drug Patent Expirations for ZORYVE
Zoryve is a drug marketed by Arcutis and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has twenty-eight patent family members in twelve countries.
The generic ingredient in ZORYVE is roflumilast. One supplier is listed for this compound. Additional details are available on the roflumilast profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com